Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy
The DOI matches its Crossref record; 54 of the 55 references it cites were found in a registry or an index.
Abstract
Voltage-gated sodium channels (Na(V)) are critical for initiation of action potentials. Heterozygous loss-of-function mutations in Na(V)1.1 channels cause severe myoclonic epilepsy in infancy (SMEI). Homozygous null Scn1a-/- mice developed ataxia and died on postnatal day (P) 15 but could be sustained to P17.5 with manual feeding. Heterozygous Scn1a+/- mice had spontaneous seizures and sporadic deaths beginning after P21, with a notable dependence on genetic background. Loss of Na(V)1.1 did not change voltage-dependent activation or inactivation of sodium channels in hippocampal neurons. The sodium current density was, however, substantially reduced in inhibitory interneurons of Scn1a+/- and Scn1a-/- mice but not in their excitatory pyramidal neurons. An immunocytochemical survey also showed a specific upregulation of Na(V)1.3 channels in a subset of hippocampal interneurons. Our results indicate that reduced sodium currents in GABAergic inhibitory interneurons in Scn1a+/- heterozygotes may cause the hyperexcitability that leads to epilepsy in patients with SMEI.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Finally, a dominant loss of function mutation in Nav1.1 causes Dravet syndrome, an intractable form of childhood-onset epilepsy that arises from a reduction in Na+ channel density in hippocampal interneurons (1255).”
From Hippocampal GABAergic Inhibitory Interneurons (2017) · cites this paper as [1255]
In the citing paper
“Haploinsufficiency or pathogenic variants of Scn1a cause Dravet Syndrome, a common and intractable form of epileptic encephalopathy characterized by the early onset of seizures17–19.”
From Viral manipulation of functionally distinct interneurons in mice, non-human primates and humans (2020) · cites this paper as [19]
In the citing paper
“As loss of expression of Scn1a is especially associated with PV cIN disfunction15–19”
From Viral manipulation of functionally distinct interneurons in mice, non-human primates and humans (2020) · cites this paper as [19]
Citations
Cites
Derivation of completely cell culture-derived mice from early-passage embryonic stem cells.
Nagy, A., Rossant, J., Nagy, R., Abramow-Newerly, W., & Roder, J. C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8424 · Cited by 2,329 · cited 1×
“The targeting construct was linearized at the Not I site in the polylinker and was electroporated into R1 embryonic stem cell”
MethodEngel, J. (2001) · Epilepsia · doi:10.1046/j.1528-1157.2001.10401.x · Cited by 2,251
From Ionic Currents to Molecular Mechanisms
Catterall, W. A. (2000) · Neuron · doi:10.1016/s0896-6273(00)81133-2 · Cited by 2,118 · cited 1×
“dtd" [ ]> Voltage-gated Na + channels in the brain are complexes of a 260-kDa α-subunit in association with auxiliary β-subunits (β1–β4) of 33 to 36 kD”
Self-citationEpileptic Syndromes in Infancy, Childhood and Adolescence
Rogers, J., Bureau, M., Dravet, C., Dreifuss, F. E., Perret, A., Wolf, P., & Armstrong, D. L. (1993) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199307000-00012 · Cited by 1,470
De Novo Mutations in the Sodium-Channel Gene SCN1A Cause Severe Myoclonic Epilepsy of Infancy
Claes, L., Del-Favero, J., Ceulemans, B., Lagae, L., Van Broeckhoven, C., & De Jonghe, P. (2001) · The American Journal of Human Genetics · doi:10.1086/320609 · Cited by 1,292
(2005) · Cited by 944
Hippocampal interneuron loss and plasticity in human temporal lobe epilepsy
de Lanerolle, N. C., Kim, J. H., Robbins, R. J., & Spencer, D. D. (1989) · Brain Research · doi:10.1016/0006-8993(89)90234-5 · Cited by 927
Buhl, E. H., Halasy, K., & Somogyi, P. (1994) · Nature · doi:10.1038/368823a0 · Cited by 728
Overview of the voltage-gated sodium channel family
Yu (2003) · Genome biology · doi:10.1186/gb-2003-4-3-207 · Cited by 694 · cited 1×
“dtd" [ ]> Voltage-gated Na + channels in the brain are complexes of a 260-kDa α-subunit in association with auxiliary β-subunits (β1–β4) of 33 to 36 kD”
Sodium channel Na v 1.6 is localized at nodes of Ranvier, dendrites, and synapses
Caldwell, J. H., Schaller, K. L., Lasher, R. S., Peles, E., & Levinson, S. R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.090034797 · Cited by 649 · cited 1×
“6 is localized in dendrites and in the nodes of Ranvie”
Background
Cited by
Items 701–800 of 1,000
Herrmann, T., Gerth, M., Dittmann, R., Pensold, D., Ungelenk, M., Liebmann, L., & Hübner, C. A. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.807090 · Cited by 11
Clinical and Functional Features of Epilepsy-Associated In-Frame Deletion Variants in SCN1A
Wang, J., Tang, B., Sheng, W.-X., Hua, L.-D., Zeng, Y., Fan, C.-X., Deng, W., Gao, M., Zhu, W., He, N., et al. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.828846 · Cited by 11
Scn1a missense mutation impairs GABAA receptor-mediated synaptic transmission in the rat hippocampus
Ohno, Y., Sofue, N., Ishihara, S., Mashimo, T., Sasa, M., & Serikawa, T. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.08.021 · Cited by 11
Anderson, M. P. (2018) · Wiley eBooks · doi:10.1002/9781119013112.ch40 · Cited by 12
Interneuron FGF13 regulates seizure susceptibility via a sodium channel-independent mechanism
Lin, S., Gade, A. R., Wang, H., Niemeyer, J. E., Galante, A., DiStefano, I. A., Towers, P., Nunez, J., Matsui, M., Schwartz, T. H., et al. (2025) · eLife · doi:10.7554/elife.98661.3 · Cited by 11
Capitano, F., Kuchenbuch, M., Lavigne, J., Chaptoukaev, H., Zuluaga, M. A., Lorenzi, M., Nabbout, R., & Mantegazza, M. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2316364121 · Cited by 11
Self-citationAdeno-Associated Viral Vectors in the Treatment of Epilepsy
Mullagulova, A., Timechko, E. E., Solovyeva, V., Yakimov, A. M., Ibrahim, A., Dmitrenko, D., Sufianov, A., Sufianova, G., & Rizvanov, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212081 · Cited by 8
Spotlight on mechanism of sudden unexpected death in epilepsy in Dravet syndrome
Shao, W., Liu, L., Gu, J., Yang, Y., Wu, Y., Zhang, Z., Xu, Q. Y., Wang, Y., Shen, Y. L., Gu, L., et al. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03304-8 · Cited by 10
Precision medicine for sodium channelopathy-related autism and epilepsy
Robinson, M. J., Wettschurack, K. W., Halurkar, M. S., Chen, X., Zhang, Z., Zhang, J., & Yang, Y. (2025) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2025.09.007 · Cited by 14
“In DS, the loss of inhibitory function isexpectedtoincreasetheE/Iratio,thustriggeringepilepticseizures[19].”
InfluentialMulley, J. C., Scheffer, I. E., Desai, T., Bayly, M. A., Grinton, B. E., Vears, D. F., Berkovic, S. F., & Dibbens, L. M. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2011.03188.x · Cited by 10
“…Inc. ª 2011 International League Against Epilepsy Epilepsia, 52(10):e139–e142, 2011 doi: 10.1111/j.1528-1167.2011.03188.x BRIEF COMMUNICATION e139 (Yu et al., 2006) and into mouse backgrounds with various knocked-in human mutations from other neuronal ion channels (Hawkins et al., 2011).”
BackgroundInfluentialCatastrophic Childhood Epilepsy: A Recent Convergence of Basic and Clinical Neuroscience
Katsnelson, A., Buzsáki, G., & Swann, J. W. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3010531 · Cited by 10
Dravet Syndrome: Inroads into Understanding Epileptic Encephalopathies
Morse, R. P. (2010) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2010.10.035 · Cited by 10
Voltage-gated sodium channels (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database
Catterall, W. A., Goldin, A. L., & Waxman, S. G. (2019) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f82/2019.4 · Cited by 14
Self-citationElleman, A. V., & Bois, J. D. (2022) · ChemBioChem · doi:10.1002/cbic.202100625 · Cited by 10
Romanova, D. Y., Balaban, P. M., & Nikitin, E. S. (2022) · Biophysica · doi:10.3390/biophysica2030019 · Cited by 12
“1-dependent AP initiation [50].”
Astrocyte Ca 2+ Signaling is Facilitated in an Scn1a +/− Mouse Model of Dravet Syndrome
Uchino, K., Tanaka, Y., Ikezawa, W., Deshimaru, M., Kubota, K., Watanabe, T., Katsurabayashi, S., Iwasaki, K., & Hirose, S. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.12.084 · Cited by 10
Epigenetic insights into GABAergic development in Dravet Syndrome iPSC and therapeutic implications
Schuster, J., Lu, X. H., Dang, Y., Klar, J., Wenz, A. S., Dahl, N., & Chen, X. (2024) · eLife · doi:10.7554/elife.92599 · Cited by 12
Ndnf interneuron excitability is spared in a mouse model of Dravet syndrome
Liebergall, S. R., & Goldberg, E. M. (2024) · Journal of Neuroscience · doi:10.1523/jneurosci.1977-23.2024 · Cited by 12
Barker‐Haliski, M. L., & Hawkins, N. A. (2024) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2024.2384455 · Cited by 13
“…models exhibited variable SRS frequency beginning in the third week of life, but new techniques have elevated SRS frequency by inducing a hyperthermia seizure in adolescent Scn1a mice prior to SRS monitoring or by manipulating the genetic background strain that maintains the mutation [42,49,50].”
Pizzamiglio, L., Capitano, F., Rusina, E., Fossati, G., Menna, E., Léna, I., Antonucci, F., & Mantegazza, M. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.106853 · Cited by 10
Self-citationOccipital seizures induced by Intermittent Photic Stimulation in Dravet syndrome
Specchio, N., Pontrelli, G., Serino, D., Trivisano, M., Cappelletti, S., Terracciano, A., Vigevano, F., & Fusco, L. (2014) · Seizure · doi:10.1016/j.seizure.2013.12.009 · Cited by 10
Pharmacologic Treatment of Intractable Epilepsy in Children: A Syndrome-Based Approach
Hussain, S. A., & Sankar, R. (2011) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2011.06.003 · Cited by 11
Impact on GABA systems in monogenetic developmental CNS disorders: Clues to symptomatic treatment
Benke, D., & Möhler, H. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.07.030 · Cited by 10
Unravelling the genetic architecture of autosomal recessive epilepsy in the genomic era
Calhoun, J. D., & Carvill, G. L. (2018) · Journal of Neurogenetics · doi:10.1080/01677063.2018.1513509 · Cited by 10
“…in the genetic epilepsies, where even for one of the most well-studied genes, SCN1A, the field still lacks consensus as to the neuronal cell-type (excitatory versus inhibitory) that plays the major role in pathogenesis (Cheah et al., 2012; Liu et al., 2013; Mistry et al., 2014; Yu et al., 2006).”
BackgroundMagalhães, P. H. M., de Moraes, H. T., Athié, M. C. P., Secolin, R., & Lopes‐Cendes, Í. (2019) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2019.07.029 · Cited by 10
SCN1A-related epilepsy with recessive inheritance: Two further families
Moretti, R., Arnaud, L., Bouteiller, D., Trouillard, O., Moreau, P., Buratti, J., Rastetter, A., Keren, B., Portes, V. D., Toulouse, J., et al. (2021) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2021.05.018 · Cited by 12
Ryazanova, M. A., Плеканчук, В. С., Prokudina, O. I., Makovka, Y. V., Alekhina, T. A., Redina, O. E., & Markel, А. L. (2023) · Biomedicines · doi:10.3390/biomedicines11071814 · Cited by 10
How Dravet syndrome became a model for studying childhood genetic epilepsies
Dravet, C. (2012) · Brain · doi:10.1093/brain/aws198 · Cited by 13
“…demonstration that the -1 subunit of the sodium channel (SCN1A) is expressed in -aminobutyric acid (GABA)ergic interneurons and its loss of function decreases their inhibitory properties on pyramidal neurons (Yu et al., 2006; Ogiwara et al., 2007) shed light on epileptogenesis in the syndrome.”
BackgroundMethodDeng, G.-F., Qin, J.-M., Sun, X., Kuang, Z.-Y., Su, T., Zhao, Q.-H., Shi, Y., Liu, X., Yu, M.-J., Yi, Y., et al. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9492-8 · Cited by 10
“Up-regulation of SCN3A has been found in haploinsufficiency of SCN1A (Yu et al. 2006) and other neurological conditions, such as peripheral nerve injury patients (Waxman 2001; Zhao et al. 2006) and Scn1b null mice with epilepsy syndrome (Chen et al. 2004), suggesting a possible role of SCN3A in…”
BackgroundInfluentialKrause, U., Alflen, C. T., Steinmetz, M., Müller, M. J., Quentin, T., & Paul, T. (2015) · Molecular and Cellular Pediatrics · doi:10.1186/s40348-015-0015-5 · Cited by 11
“Such animals have been established [31] but characterization of the electrical properties of the animal cardiomyocytes is still lacking.”
BackgroundHarnessing the Flow of Excitation
Frolov, R. V., & Weckström, M. (2015) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2015.11.001 · Cited by 13
Yip, K. L., Udoh, M., Sharman, L. A., Harman, T., Bedoya‐Pérez, M. A., Anderson, L. L., Banister, S. D., & Arnold, J. C. (2024) · Epilepsia · doi:10.1111/epi.18177 · Cited by 9
“18,19 Lennox–Gastaut syndrome is another childhood epilepsy characterized by drug-resistant seizures, most commonly tonic, atonic, and atypical absence seizures.”
Richards, K., Jancovski, N., Hanssen, E. G., Connelly, A., & Petrou, S. (2020) · Brain Research · doi:10.1016/j.brainres.2020.147157 · Cited by 10
Mantegazza, M., Auvin, S., Barker‐Haliski, M. L., Katsarou, A., Kubová, H., Galanopoulou, A. S., Semple, B. D., & Reid, C. A. (2022) · Epilepsia Open · doi:10.1002/epi4.12642 · Cited by 11
“13,14 The latter category includes both monogenic strains— for example, mice carrying spontaneous variants in Scn8a , leading to loss- of-function of the Na V 1.6 sodium channel and a phenotype of absence seizures and movement dysfunctions 15 — as well as polygenic inbred strains, such as genetic…”
InfluentialSelf-citationGuo, J., Min, D., Farrell, E. K., Zhou, Y., Faingold, C. L., Cotten, J. F., & Feng, H. (2024) · Epilepsia · doi:10.1111/epi.17966 · Cited by 10
Johnson, J. P., Focken, T., Tari, P. K., Dubé, C. M., Goodchild, S. J., Andrez, J., Bankar, G. R., Burford, K., Chang, E., Chowdhury, S., et al. (2024) · British Journal of Pharmacology · doi:10.1111/bph.16481 · Cited by 9
“Mouse models of Dravet Syndrome created by heterozygous knock out of Na V 1.1 are prone to seizures and sudden death (Ogiwara et al., 2007; Yu et al., 2006).”
InfluentialLee, S.-H., Kang, Y., & Smith, B. N. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106737 · Cited by 11
“…abnormalities in PV + interneurons described here (i.e., reduced AP firing rate, increased rheobase, and increased AP threshold) are reminiscent of those commonly found in mouse models of Dravet syndrome (Kaneko et al., 2022; Ogiwara et al., 2007; Rubinstein et al., 2015; Yu et al., 2006).”
Serotonin abnormalities in Dravet syndrome mice before and after the age of seizure onset
Hatini, P. G., & Commons, K. G. (2019) · Brain Research · doi:10.1016/j.brainres.2019.146399 · Cited by 9
Turning strains into strengths for understanding psychiatric disorders
Moore, S. J., Murphy, G. G., & Cazares, V. A. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0772-y · Cited by 10
Migraine and epilepsy: genetically linked?
Haan, J., van den Maagdenberg, A. M. J. M., Brouwer, O. F., & Ferrari, M. D. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.8.9.1307 · Cited by 9
Farmacogenética e antiepilépticos (farmacologia das drogas antiepilépticas: da teoria à prática)
Silvado, C. E. (2008) · Journal of Epilepsy and Clinical Neurophysiology · doi:10.1590/s1676-26492008000600009 · Cited by 9
Antiepileptic drugs and migraine
Rogawski, M. A. (2008) · Oxford University Press eBooks · doi:10.1093/med/9780199552764.003.0020 · Cited by 10
“Often this is a gain-of-function increase in excitability, but in some instances there may be a reduction in excitability in a specific cell population (for example in inhibitory interneurons) that lead to a net increase in circuit excitability (as in severe myoclonic epilepsy in infancy; Yu et al., 2006).”
Crestey, F., Frederiksen, K., Jensen, H. S., Dekermendjian, K., Larsen, P. H., Bastlund, J. F., Lu, D., Liu, H., Yang, C. R., Grunnet, M., et al. (2015) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00147 · Cited by 9
Goldman, A. M., Buchanan, G. F., Aiba, I., & Noebels, J. L. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804066-9.00070-5 · Cited by 12
Isom, L. L. (2019) · Epiliepsy currents/Epilepsy currents · doi:10.1177/1535759719844780 · Cited by 9
“1 Scn1a haploinsufficiency in mice results in severe seizures and SUDEP.2 Neonatal (postnatal day [P] 14-16) Scn1aþ/ mice have reduced sodium current density and reduced action potential firing in hippocampal GABAergic inhibitory neurons with no detectable effects on excitatory pyramidal neurons.2 Similarly, reduced s…”
InfluentialSodium Channelopathies in Human and Animal Models of Epilepsy and Neurodevelopmental Disorders
Yamakawa, K., Meisler, M. H., & Isom, L. L. (2024) · Oxford University Press eBooks · doi:10.1093/med/9780197549469.003.0044 · Cited by 17
Differential encoding of mammalian proprioception by voltage-gated sodium channels
Espino, C. M., Nagaraja, C., Ortiz, S., Dayton, J. R., Murali, A. R., Ma, Y. –., Mann, E., Garlapalli, S., Wohlgemuth, R. P., Brashear, S. E., et al. (2025) · Science Advances · doi:10.1126/sciadv.ads6660 · Cited by 10
“In contrast, Na V 1.1 is localized to the soma and proximal AIS, where it aids in repetitive firing in fast spiking neurons of the brain ( 14 , 50 ).”
InfluentialBalestrini, S., & Scheffer, I. E. (2026) · CNS Drugs · doi:10.1007/s40263-026-01276-x · Cited by 11
“Studies in Scn1a knockout mouse models showed that reduced Na + -current density results in decreased excitability of parvalbumin-and somatostatin-positive inhibitory interneurons, leading to impaired inhibitory control and promoting epileptogenesis [10–12].”
Ikram, M. D., & Rasheed, S. (2022) · Current Molecular Pharmacology · doi:10.2174/1874467215666220819143105 · Cited by 8
Lemaire, L., Desroches, M., Крупа, М. М., & Mantegazza, M. (2023) · Journal of Mathematical Biology · doi:10.1007/s00285-023-01917-5 · Cited by 8
“This is for example the case of Dravet syndrome (Claes et al. 2001;Yu et al. 2006), a severe formof epilepsy, characterized by drug-resistant seizures and developmental delay.”
BackgroundSelf-citationAlfayyadh, M. M., Maksemous, N., Sutherland, H. G. E., Lea, R. A., & Griffiths, L. R. (2024) · Genes · doi:10.3390/genes15040443 · Cited by 11
“These channels control the production and propagation of excitation actions in the neuronal cells [49,96].”
BackgroundSudden Unexpected Death in Epilepsy: Central Respiratory Chemoreception
Dereli, A. S., Apaire, A., & Tahry, R. E. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26041598 · Cited by 10
“…many aspects of the clinical condition and offers a research tool for understanding mechanisms of SUDEP in DS. Global heterozygous knockout (KO) of Scn1a is a popular model for DS and leads to an early onset of seizures, starting at P21 [109,110], with high susceptibility to hyperthermia [111].”
Zayat, V., Szlendak, R., & Hoffman‐Zacharska, D. (2022) · Cells · doi:10.3390/cells11193119 · Cited by 9
“Such mouse models demonstrated that DRVT occurs due to the reduced excitability of GABAergic interneurons, and finally, neuronal network hyperexcitability [35], and those missense mutations identified in GEFS+ and DRVT patients show a common pathogenic mechanism for both disorders.”
BackgroundFeng, Y.-J., Zhang, S., Zhang, Z., Guo, J., Tan, Z., Zhu, Y., Tao, J., & Ji, Y. (2018) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527317666181026164825 · Cited by 8
The effect of sodium channels on neurological/neuronal disorders: A systematic review
Bagheri, S., Haddadi, R., Saki, S., Kourosh‐Arami, M., & Komaki, A. (2021) · International Journal of Developmental Neuroscience · doi:10.1002/jdn.10153 · Cited by 9
“1 is linked to multiple epilepsy syndromes and autism (D’Gama et al., 2015; Yu et al., 2006) (Table 1).”
BackgroundHernández, A. V. M., Vila, M. T., Caro‐Llopis, A., Monfort, S., & Martínez, F. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.784892 · Cited by 8
Channelopathy of Dravet Syndrome and Potential Neuroprotective Effects of Cannabidiol
Xu, C., Zhang, Y., Gozal, D., & Carney, P. R. (2021) · Journal of Central Nervous System Disease · doi:10.1177/11795735211048045 · Cited by 10
Catterall, W. A. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.x115.683383 · Cited by 8
Self-citationShorvon, S. D., Andermann, F., & Guerrini, R. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511921001.003 · Cited by 8
Bukhteeva, I., Livingstone, J. D., Singh, K., Pavlov, E. V., Beazely, M. A., Gingras, M. J. P., & Leonenko, Z. (2025) · Scientific Reports · doi:10.1038/s41598-025-12893-9 · Cited by 7
“1 is predominant in inhibitory gamma aminobutyric acid-ergic (GABAergic) interneurons 31,32 Nav1.”
Godad, A. P., Kelkar, S., Nailwal, N. P., Bhatia, N. Y., Doshi, G., & Sathaye, S. S. (2022) · Current Drug Targets · doi:10.2174/1389450123666220819141827 · Cited by 10
Successful treatment of pediatric patient with Dravet syndrome with cenobamate: Case report
Lobanov, O. V., & Bertrand, M. E. (2025) · SAGE Open Medical Case Reports · doi:10.1177/2050313x251324079 · Cited by 7
Animal models for evaluating antiepileptogenesis
White, H. S. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2010.02873.x · Cited by 7
Mapt deletion fails to rescue premature lethality in two models of sodium channel epilepsy
Chen, C., Holth, J. K., Bunton-Stasyshyn, R. K. A., Anumonwo, C., Meisler, M. H., Noebels, J. L., & Isom, L. L. (2018) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.599 · Cited by 9
Quinn, S., Brusel, M., Ovadia, M., & Rubinstein, M. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1118216 · Cited by 7
Manning, A. A., Han, V. Z., Stephens, A., Wang, R., Bush, N. E., Bard, M., Ramirez, J., & Kalume, F. K. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106288 · Cited by 8
Self-citationConservation-based prediction of the transcription regulatory region of the SCN1A gene
Long, Y., Shi, Y., & Liao, W. (2009) · Progress in Natural Science Materials International · doi:10.1016/j.pnsc.2009.09.004 · Cited by 7
Isom, L. L. (2017) · Epiliepsy currents/Epilepsy currents · doi:10.5698/1535-7597.17.4.244 · Cited by 7
von Schoubye, N. L., Frederiksen, K., Kristiansen, U., Petersen, A. V., Dalby, N. O., Grunnet, M., Jensen, H. S., Jespersen, T., Sohal, V. S., & Perrier, J. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.10.004 · Cited by 8
Epilepsy channelopathies go neddy: stabilizing NaV1.1 channels by neddylation
Cannon, S. C. (2021) · Journal of Clinical Investigation · doi:10.1172/jci148370 · Cited by 7
An advance about the genetic causes of epilepsy
Sun, Y., Lu, L., Li, L., & Wang, J. (2021) · E3S Web of Conferences · doi:10.1051/e3sconf/202127103068 · Cited by 10
Anti-seizure efficacy of perampanel in two established rodent models of early-life epilepsy
Roberts, N. S., Handy, M., Ito, Y., Hashimoto, K., Jensen, F. E., & Talos, D. M. (2023) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2023.109194 · Cited by 7
Predicting the impact of sodium channel mutations in human brain disease
Noebels, J. L. (2019) · Epilepsia · doi:10.1111/epi.14724 · Cited by 7
Neurophysiological and Genetic Findings in Patients With Juvenile Myoclonic Epilepsy
Stefani, S., Kousiappa, I., Nicolaou, N., Papathanasiou, E. S., Oulas, A., Fanis, P., Neocleous, V., Phylactou, L. A., Spyrou, G. M., & Papacostas, S. (2020) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2020.00045 · Cited by 8
Cheah, C. S., Beckman, M., Catterall, W. A., & Oakley, J. C. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.751762 · Cited by 7
Self-citationShore, A. N., Li, K., Safari, M., Qunies, A. M., Spitznagel, B. D., Weaver, C. D., Emmitte, K. A., Frankel, W. N., & Weston, M. C. (2024) · eLife · doi:10.7554/elife.92915.4 · Cited by 11
Baspinar, E., Simonti, M., Srour, H., Desroches, M., Avitabile, D., & Mantegazza, M. (2025) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1013099 · Cited by 7
“1 plays a key role in the excitability of GABAergic inhibitory neurons [39].”
Self-citationGargus, J. J., & Haier, R. J. (2025) · Intelligence & Cognitive Abilities · doi:10.65550/001c.146520 · Cited by 6
Long‐lasting remodeling of astrocytes in an Scna1 +/− mouse model of Dravet syndrome
Génin, A., Janvier, A., Moujellil-Legagneur, T., Blaquière, M., Chaussy, A., Privé, R., Duprat, F., Mantegazza, M., Audinat, É., Marchi, N., et al. (2026) · Epilepsia · doi:10.1002/epi.70185 · Cited by 8
“11 Here, we examine how genetically driven seizures accompanied by progressive behavioral deficits in DS trigger or are associated with secondary responses: cellular modifications extending beyond neurons, with a particular focus on astrocytes.”
Self-citationDepressed glutamate transporter 1 expression in a mouse model of Dravet syndrome
Hameed, M. Q., Hui, B., Lin, R., MacMullin, P., Pascual-Leone, A., Vermudez, S. A. D., & Rotenberg, A. (2023) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51851 · Cited by 6
Krishna, S., Fasaludeen, A., Jose, M., Banerjee, M., Sundaram, S., Radhakrishnan, A., & Menon, R. N. (2024) · Seizure · doi:10.1016/j.seizure.2024.01.004 · Cited by 6
Pereira, M. F., Shyti, R., & Testa, G. (2024) · Stem Cell Reports · doi:10.1016/j.stemcr.2024.05.004 · Cited by 8
Gene therapy for Dravet syndrome: promises and impact on disease trigger and secondary modifications
Berardino, C. D., Massimino, L., Ungaro, F., & Colasante, G. (2024) · Rare Disease and Orphan Drugs Journal · doi:10.20517/rdodj.2024.07 · Cited by 6
Abnormal increased mTOR signaling regulates seizure threshold in Dravet syndrome.
Tsai, C.-W., Ho, S.-Y., Chen, C. I., Chang, K.-C., Chen, H.-J., Tsai, F.-C., & Liou, H.-H. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.110166 · Cited by 5
Chen, I.-C., Ho, S., Tsai, C., Chen, E.-L., & Liou, H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252312721 · Cited by 6
Ion currents through the voltage sensor domain of distinct families of proteins
Arcos-Hernández, C., & Nishigaki, T. (2023) · Journal of Biological Physics · doi:10.1007/s10867-023-09645-z · Cited by 7
“On the other hand, a mutation of the inactivation process of Na v 1.1 channel can result in an opposite effect, namely establishing a constant current that leads to hyperexcitability (gain of function) [28, 29].”
BackgroundInfluentialAnother cause of vaccine encephalopathy: A case of Angelman syndrome
Nový, J., Catarino, C. B., Chinthapalli, K., Smith, S. J. M., Clayton‐Smith, J., Hennekam, R. C. M., Hammond, P., & Sisodiya, S. M. (2012) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2012.01.008 · Cited by 6
Chao, D., & Xia, Y. (2015) · Springer eBooks · doi:10.1007/978-3-319-25495-1_16 · Cited by 7
Liu, W., Lao, W., Zhang, R., & Zhu, H. (2021) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2021.02.017 · Cited by 6
Smith, B. J., McHugh, C. F., Hirano, A. A., Brecha, N. C., & Barnes, S. (2023) · Journal of Neuroscience · doi:10.1523/jneurosci.1723-22.2023 · Cited by 7
“This is similar to studies of Na V 1.1 knock-out mice, which show a similar deficit in repetitive spiking (Yu et al., 2006; Ogiwara et al., 2007).”
ResultInfluentialFukushima, K., Higashiyama, H., Kazuta, Y., Hashimoto, K., Watanabe, N., Furuya, Y., Ito, Y., Wu, T., Kosasa, T., Talos, D. M., et al. (2023) · Epilepsia Open · doi:10.1002/epi4.12741 · Cited by 7
Albaradie, R. (2013) · Neurosciences · doi:10.17712/1658-3183.1986 · Cited by 8
Cooper, E. C., & Pan, Z. (2007) · Neurology · doi:10.1212/01.wnl.0000275538.19348.bd · Cited by 6
Hammer, M. F. (2025) · Bioscience Reports · doi:10.1042/bsr20253356 · Cited by 8
“SCN1A LoF variants primarily affect inhibitory circuits, creating a paradox where LoF mutations produce epilepsy phenotypes similar to GoF variants in excitatory Nav channels, but through reduced inhibition rather than direct hyperexcitation [13,14].”
From Symptomatic Therapies to Disease-Modifying Approaches for Neuronal Sodium Channel Disorders
Dinoi, G., Canfora, I., D’Agnano, D., Boccanegra, B., Conte, E., Luca, A. D., Liantonio, A., Sciruicchio, V., & Imbrici, P. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms27010032 · Cited by 7
“Studies in mouse models have demonstrated that LOF in Scn1a leads to reduced inhibitory output from GABAergic interneurons, resulting in cortical hyperexcitability and seizures [33–35].”
Heterogeneous Mechanisms of Spreading Depolarization and Seizures
Aiba, I. (2024) · Oxford University Press eBooks · doi:10.1093/med/9780197549469.003.0062 · Cited by 8
Danno, D., Tada, H., Oda, I., Kawashita, N., Hirano, M., Kitamura, S., Kikui, S., Samukawa, M., Yoshikawa, K., Mitsui, Y., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26041426 · Cited by 5
“1 than those underlying milder phenotypes [21,22].”
Dysregulation of the Cannabinoid System in Childhood Epilepsy: From Mechanisms to Therapy
Montebello, G., & Giovanni, G. D. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136234 · Cited by 6
“Ho-mozygous Scn1a knockout mice develop ataxia and die at 15 days postnatal, whereas heterozygous Scn1a-deficient mice show seizure activity and early mortality starting at 3 weeks of age [50,51].”
Animal Models for Evaluating Antiepileptogenesis
White, H. S. (2012) · Oxford University Press eBooks · doi:10.1093/med/9780199746545.003.0080 · Cited by 5
Retinal Tissue Shows Glial Changes in a Dravet Syndrome Knock-in Mouse Model
Salazar, J. J., Satriano, A., Matamoros, J. A., Fernández‐Albarral, J. A., Salobrar‐García, E., López‐Cuenca, I., de Hoz, R., Sánchez-Puebla, L., Ramirez, J. M., Alonso, C., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032727 · Cited by 5
“Numerous murine models have been developed given the genetic origin of this disease [12,13,39,40].”
Background
Metadata
- Authors
- Yu, F. H., Mantegazza, M., Westenbroek, R. E., Robbins, C. A., Kalume, F., Burton, K. A., Spain, W. J., McKnight, G. S., Scheuer, T., & Catterall, W. A.
- Affiliations
- University of Washington (US)
- Corresponding author
- Catterall, William A
- ORCID
- Venue
- Nature Neuroscience
- Published
- 2006-08-20
- Volume
- 9
- Issue
- 9
- Pages
- 1142-1149
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- OpenAlex
- W2105423985
- Cited by
- 1,173
- References
- 55
- Citations by year
- 2026: 54 · 2025: 72 · 2024: 66 · 2023: 69 · 2022: 73 · 2021: 85 · 2020: 70 · 2019: 70 · 2018: 53 · 2017: 59 · 2016: 47 · 2015: 63 · 2014: 64 · 2013: 64 · 2012: 52
- FWCI
- 22.30
- Type
- journal article
- Language
- en
- Update notices
- erratum (2007-01-01)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Keywords
- Dravet syndrome, SCN1A, Nav1.3, GABAergic interneurons, sodium current, hippocampus, neuronal hyperexcitability, epilepsy, genetic background effects
- MeSH terms
- Action Potentials, Animals, Cell Line, Disease Models, Animal, Electroencephalography, Epilepsies, Myoclonic, gamma-Aminobutyric Acid, Genotype, Humans, Infant, Interneurons, Mice, Inbred C57BL, Mice, Inbred Strains, Mutation, Nerve Tissue Proteins, Phenotype, Seizures, Immunoblotting, Sodium Channels, Survival Rate, Mice, Knockout, Patch-Clamp Techniques, Mice, NAV1.1 Voltage-Gated Sodium Channel
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.